Intellia Therapeutics Stock Forecast

Stock Price Forecast

The 19 analysts that cover Intellia Therapeutics stock have a consensus rating of "Buy" and an average price target of $20.45, which forecasts a 49.71% increase in the stock price over the next year. The lowest target is $5.00 and the highest is $48.

Price Target: $20.45 (+49.71%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$5.00	$20.45	$15	$48
Change	-63.40%	+49.71%	+9.81%	+251.39%

Analyst Ratings

The average analyst rating for Intellia Therapeutics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Oct '25	Nov '25	Dec '25	Jan '26	Feb '26	Mar '26
Strong Buy	7	7	7	7	7	8
Buy	5	4	4	2	2	4
Hold	8	10	10	8	8	7
Sell	0	1	1	1	1	1
Strong Sell	0	0	0	0	0	0
Total	20	22	22	18	18	20

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Debanjana Chatterjee Jones Trading	Jones Trading	Hold → Strong Buy Upgrades $29	Hold → Strong Buy	Upgrades	$29	+112.30%	Mar 4, 2026
Whitney Ijem Canaccord Genuity	Canaccord Genuity	Strong Buy Maintains $54 → $48	Strong Buy	Maintains	$54 → $48	+251.39%	Mar 3, 2026
Mani Foroohar Leerink Partners	Leerink Partners	Buy Maintains $27 → $29	Buy	Maintains	$27 → $29	+112.30%	Mar 3, 2026
Luca Issi RBC Capital	RBC Capital	Hold Maintains $9 → $15	Hold	Maintains	$9 → $15	+9.81%	Mar 3, 2026
Yanan Zhu Wells Fargo	Wells Fargo	Hold Maintains $12 → $15	Hold	Maintains	$12 → $15	+9.81%	Mar 3, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

60.24M

from 67.67M

-10.98%

from 67.67M

Revenue Next Year

104.26M

from 60.24M

73.07%

from 60.24M

EPS This Year

-3.71

from -3.81

EPS Next Year

-3.02

from -3.71

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	33.05M	52.12M	36.28M	57.88M	67.67M	60.24M	104.26M
Revenue Growth	-43.01%	57.69%	-30.40%	59.55%	16.92%	-10.98%	73.07%
EPS	-3.78	-6.16	-5.42	-5.25	-3.81	-3.71	-3.02
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	25	22

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026	2027
High	105.0M	252.0M
Avg	60.2M	104.3M
Low	8.8M	29.9M

Revenue Growth

Revenue Growth	2026	2027
High	55.2%	318.3%
Avg	-11.0%	73.1%
Low	-87.0%	-50.4%

EPS Forecast

EPS	2026	2027
High	-2.04	-1.64
Avg	-3.71	-3.02
Low	-4.71	-4.59

EPS Growth

EPS Growth	2026	2027
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.